ATOSSA THERAPEUTICS, INC. — Director's Dealing 2013

Oct 16, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ATOSSA GENETICS INC (ATOS)
CIK: 0001488039
Period of Report: 2013-10-10

Reporting Person: WEAVER GREGORY L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-10-10	Common Stock	A	24510	—	Acquired	24510	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-10-10	Stock Option (right to buy)	$2.04	A	57190	Acquired	2023-10-10	Common Stock (57190)	Direct

Footnotes

F1: Represents an award of Restricted Stock Units that vests quarterly over one year from October 10, 2013.

F2: Not Applicable.

F3: The option vests and becomes exercisable in three equal installments between October 10, 2013 and the 2014 annual meeting of stockholders.